Cargando…

Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction

Cellular transformation is associated with altered glutamine (Gln) metabolism. Tumor cells utilize Gln in the tricarboxylic acid (TCA) cycle to maintain sufficient pools of biosynthetic precursors to support rapid growth and proliferation. However, Gln metabolism also generates NADPH, and Gln-derive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cetinbas, Naniye, Daugaard, Mads, Mullen, Andrew, Hajee, Shamil, Rotblat, Barak, Lopez, Alejandra, Li, Amy, DeBerardinis, Ralph J, Sorensen, Poul H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387113/ https://www.ncbi.nlm.nih.gov/pubmed/25284589 http://dx.doi.org/10.1038/onc.2014.316

Ejemplares similares

Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine
por: Cetinbas, Naniye Mallı, et al.
Publicado: (2016)

Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes
por: Daugaard, Mads, et al.
Publicado: (2013)

HACE1 is a potential tumor suppressor in osteosarcoma
por: El-Naggar, Amal M, et al.
Publicado: (2019)

The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate
por: Tortola, Luigi, et al.
Publicado: (2016)

The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate
por: Tortola, Luigi, et al.
Publicado: (2016)

Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation
por: Andrio, Emilie, et al.
Publicado: (2017)

Lkb1 deficiency confers glutamine dependency in polycystic kidney disease
por: Flowers, Ebony M., et al.
Publicado: (2018)

HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner
por: Turgu, Busra, et al.
Publicado: (2021)

Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division
por: Petracchini, Serena, et al.
Publicado: (2022)

Targeting Glutamine Addiction in Gliomas
por: Obara-Michlewska, Marta, et al.
Publicado: (2020)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Metabolic heterogeneity in cancer
por: DeBerardinis, Ralph J
Publicado: (2014)

Q&A: Targeting metabolism to diagnose and treat cancer
por: DeBerardinis, Ralph J
Publicado: (2014)

Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model
por: Oizel, Kristell, et al.
Publicado: (2020)

Pyruvate dehydrogenase activity is required for optimal growth under lipid deficient conditions
por: Rajagopalan, Kartik, et al.
Publicado: (2014)

Fundamentals of cancer metabolism
por: DeBerardinis, Ralph J., et al.
Publicado: (2016)

Glutamine Addiction and Therapeutic Strategies in Lung Cancer
por: Vanhove, Karolien, et al.
Publicado: (2019)

Distinct effects of etoposide on glutamine-addicted neuroblastoma
por: Valter, Kadri, et al.
Publicado: (2019)

Control of Glutamine Metabolism By the Tumor Suppressor Rb
por: Reynolds, Miriam R., et al.
Publicado: (2013)

Cellular immunity changes after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome
por: Cetinbas, F, et al.
Publicado: (2006)

From “N of 1” to N of more
por: DeBerardinis, Ralph J., et al.
Publicado: (2015)

Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma
por: Ratnikov, Boris, et al.
Publicado: (2015)

TAp73 is a marker of glutamine addiction in medulloblastoma
por: Niklison-Chirou, Maria Victoria, et al.
Publicado: (2017)

Hopefully devoted to Q: targeting glutamine addiction in cancer
por: Still, Emma R, et al.
Publicado: (2017)

Glutamine synthetase: a tumor suppressor in hepatocellular carcinoma?
por: Dai, Weiwei, et al.
Publicado: (2023)

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemia
por: Nguyen, Tra Ly, et al.
Publicado: (2021)

Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
por: Chakrabarti, Gaurab, et al.
Publicado: (2015)

Metabolic changes in cancer cells upon suppression of MYC
por: Anso, Elena, et al.
Publicado: (2013)

Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells
por: Smith, Bradley, et al.
Publicado: (2016)

Correction: Hopefully devoted to Q: targeting glutamine addiction in cancer
por: Still, Emma R., et al.
Publicado: (2019)

Hace mucho tiempo
por: Kennedy, Margaret, 1896-1967
Publicado: (1948)

Oncogenes and Tumor Suppressors Regulate Glutamine Metabolism in Cancer Cells
por: Kim, Min Hyun, et al.
Publicado: (2013)

HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress
por: Zhang, Liyong, et al.
Publicado: (2014)

Vitamin B6-dependent epilepsy due to pyridoxal phosphate-binding protein (PLPBP) defect – First case report from Pakistan and review of literature
por: Ahmed, Sibtain, et al.
Publicado: (2020)

Glutamine addiction promotes glucose oxidation in triple-negative breast cancer
por: Quek, Lake-Ee, et al.
Publicado: (2022)

YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1
por: Somasekharan, Syam Prakash, et al.
Publicado: (2015)

Qué nos hace humanos
por: Ridley, Matt
Publicado: (2004)

El psicólogo ?que hace?
por: Harrsch, Catalina
Publicado: (1991)

Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors
por: Khazamipour, Nastaran, et al.
Publicado: (2020)

Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival
por: Sanchez, Erica L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7f3304gosbr9lcsdj55ercboev